eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
IMPACT FACTOR
1.5
MNiSW
20*
Indexed in:
ESCI

Web of Science
Clarivate Analytics
JCI
0.31

Journal Citation Indicator
CiteScore 2022
3
 
NEW Guidelines for Authors!

The current MNiSW score is temporary and results from the decision of the Minister of Science and Higher Education to withdraw scores from all journals that received an increase in score in 2023. The decision is the result of the need to develop a new scoring system. However, all articles published in 2023 are awarded 200 MNiSW points, and the actual score for 2024 will be determined at the end of the year.

Obecna punktacja MEiN ma charakter tymczasowy i wynika z decyzji Ministra Nauki i Szkolnictwa Wyższego o wycofaniu punktacji wszystkim czasopismom, które w 2023 r. uzyskały podwyższenie punktacji. Decyzja ta wynika z konieczności opracowania nowego systemu punktacji. Natomiast wszystkie artykuły opublikowane w roku 2023 otrzymują 200 punktów MNiSW, a ostateczna punktacja za rok 2024 zostanie ustalona na koniec roku.


Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.

Indexed in PubMed and Web of Science Core Collection
3/2019
vol. 5
 
 

 
Review paper

Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation

Małgorzata Pawłowska, Robert Flisiak, Lidia Gil, Andrzej Horban, Iwona Hus, Jerzy Jaroszewicz, Ewa Lech-Marańda, Jan Styczyński
Clin Exp HEPATOL 2019; 5, 3:195–202
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87631
Review paper

Hepatobiliary manifestations of inflammatory bowel disease in children

Magdalena Kucharska, Urszula Daniluk, Kamila Agnieszka Kwiatek-Średzińska, Natalia Wasilewska, Aleksandra Filimoniuk, Piotr Jakimiec, Katarzyna Zdanowicz, Dariusz Marek Lebensztejn
Clin Exp HEPATOL 2019; 5, 3: 203–209
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87632
Original paper

Perspectives of hepatitis C virus (HCV) elimination in Poland

Robert Flisiak, Dorota Zarębska-Michaluk
Clin Exp HEPATOL 2019; 5, 3: 210–214
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87633
Original paper

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study

Krzysztof Adam Simon, Robert Flisiak, Tadeusz Wojciech Łapiński, Ewa Janczewska, Marta Wawrzynowicz-Syczewska, Jerzy Jaroszewicz, Dorota Zarębska-Michaluk, Khalil Nazzal, Beata Bolewska, Jolanta Białkowska, Hanna Berak, Katarzyna Fleischer-Stępniewska, Krzysztof Tomasiewicz, Kornelia Karwowska, Karolina Anna Rostkowska, Anna Piekarska, Olga Tronina, Grzegorz Madej, Aleksander Garlicki, Mariusz Łucejko, Arkadiusz Pisula, Ewa Karpińska, Wiesław Kryczka, Alicja Wiercińska-Drapało, Iwona Mozer-Lisewska, Maciej Stanisław Jabłkowski, Andrzej Horban, Brygida Knysz, Magdalena Tudrujek, Waldemar Halota
Clin Exp HEPATOL 2019; 5, 3: 215–223
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87634
Original paper

Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study

Elaheh Zarean, Reza Goujani, Ghorbanali Rahimian, Ali Ahamdi
Clin Exp HEPATOL 2019; 5, 3: 224–231
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87635
Original paper

Prevalence of hepatitis delta infections among HBs-antigen-positive inhabitants of southeastern and northwestern parts of Poland

Robert Pleśniak, Marta Wawrzynowicz-Syczewska
Clin Exp HEPATOL 2019; 5, 3: 232–236
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87636
Original paper

Acute effects of different doses of malathion on the rat liver

Çınar Severcan, Murat Ekremoglu, Bayram Sen, Ozge Tugce Pasaoglu, Nalan Akyurek, Suzan Muratoglu Severcan, Hatice Pasaoglu
Clin Exp HEPATOL 2019; 5, 3: 237–243
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87637
Original paper

Transient elastography reliably estimates liver fibrosis in autoimmune hepatitis

Nadim Mahmud, Sahil D. Doshi, Kimberly A. Forde, Vandana Khungar
Clin Exp HEPATOL 2019; 5, 3: 244–249
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87639
Original paper

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct

Vor Luvira, Supot Kamsa-ard, Ake Pugkhem, Varisara Luvira, Tharatip Srisuk, Attapol Titapun, Artit Silsirivanit, Sopit Wongkham, Narong Khuntikeo, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi
Clin Exp HEPATOL 2019; 5, 3: 250–255
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87641
Original paper

Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response

Hala A. Agina, Nermine A. Ehsan, Taghreed A. Abd-Elaziz, Ghada A. Abd-Elfatah, Eman M. Said, Mostafa M. Sira
Clin Exp HEPATOL 2019; 5, 3: 256–264
Online publish date: 2019-09-05
 
DOI : https://doi.org/10.5114/ceh.2019.87642
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.